文献速递儿科与产科急症消化、代谢与肾脏急症

1、2、3级肥胖孕妇低体重增长或体重下降的安全性:一项基于人群的队列研究

Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study.
PubMed 文献 · Lancet · 2024-03-28
一句话结论在1、2级肥胖孕妇中,体重增长低于IOM推荐下限或体重下降未增加不良复合结局风险;3级肥胖孕妇体重增长低于IOM下限或体重下降与不良复合结局风险降低相关(调整RR 0.81)。

该基于人群的队列研究纳入2008年1月1日至2015年12月31日分娩、早孕期(<14周)BMI≥30 kg/m2的单胎妊娠15 760例,随访至2019年12月31日,中位随访7.9年(IQR 5.8-9.4)。以当前IOM推荐下限(足月5 kg)为参照,评估妊娠期体重增长z-score与不良复合结局(死产、婴儿死亡、大于/小于胎龄儿、早产、非计划剖宫产、妊娠期糖尿病、子痫前期、产后体重滞留过多、产后新发长期母体心血管代谢疾病)的关联。1级或2级肥胖孕妇体重增长低于IOM下限或体重下降未增加不良复合结局风险(如z-score -2.4、40周时0 kg:1级调整RR 0.97 [95%CI 0.89-1.06],2级0.96 [0.86-1.08]);3级肥胖孕妇体重增长低于IOM下限或体重下降与不良复合结局风险降低相关(z-score -2.4、0 kg时调整RR 0.81 [0.71-0.89])。作者认为研究结果支持降低或取消当前IOM对肥胖孕妇的体重增长下限,并提示可能需要为3级肥胖制定单独指南。

要点

  • 1级或2级肥胖孕妇体重增长低于IOM下限(5 kg)或体重下降未增加不良复合结局风险(z-score -2.4、40周0 kg时调整RR分别为0.97 [0.89-1.06]和0.96 [0.86-1.08])。
  • 3级肥胖孕妇体重增长低于IOM下限或体重下降与不良复合结局风险降低相关(z-score -2.4、0 kg时调整RR 0.81 [0.71-0.89])。
  • 队列中体重增长低于IOM下限(5 kg)的比例:1级肥胖13.9%(1623例)、2级肥胖24.9%(786例)、3级肥胖33.2%(310例)。
  • 作者认为研究结果支持降低或取消当前IOM对肥胖孕妇的体重增长下限,并提示可能需要为3级肥胖制定单独指南。
  • 研究纳入早孕期(<14周)BMI≥30 kg/m2的单胎妊娠15 760例,中位随访7.9年(IQR 5.8-9.4)。

适用人群与场景

  • 早孕期(<14周)BMI≥30 kg/m2的单胎妊娠,分娩时间在2008年1月1日至2015年12月31日之间,来自Stockholm-Gotland围产队列。

诊断标准与关键阈值

  • 肥胖定义:早孕期(<14周)BMI≥30 kg/m2。
  • 体重增长计算:分娩前或分娩时最后一次测量体重减去早孕期(<14周)体重,并按孕龄标准化为z-score。
  • 参照值:美国医学研究所(IOM)推荐的妊娠期体重增长下限(足月5 kg)。

研究设计与关键结果

  • 研究类型:基于人群的队列研究;样本量:15 760例肥胖孕妇;中位随访7.9年(IQR 5.8-9.4)。
  • 肥胖分级构成:1级肥胖11 667例(74.0%)、2级肥胖3160例(20.1%)、3级肥胖933例(5.9%)。
  • 体重增长低于IOM下限(5 kg)的比例:1级肥胖1623例(13.9%)、2级肥胖786例(24.9%)、3级肥胖310例(33.2%)。
  • 主要终点为不良复合结局:死产、婴儿死亡、大于胎龄儿、小于胎龄儿、早产、非计划剖宫产、妊娠期糖尿病、子痫前期、产后体重滞留过多、产后新发长期母体心血管代谢疾病,按事件严重程度加权。
  • 1级肥胖:体重增长z-score -2.4(对应40周时0 kg)时,调整RR 0.97(95%CI 0.89-1.06);2级肥胖:调整RR 0.96(95%CI 0.86-1.08);均未达统计学显著。
  • 3级肥胖:体重增长z-score -2.4(对应40周时0 kg)时,调整RR 0.81(95%CI 0.71-0.89),与不良复合结局风险降低相关。
  • 调整的混杂因素:母亲年龄、身高、产次、早孕期BMI、早孕期吸烟状态、孕前心血管疾病或糖尿病、教育程度、同居状态、北欧国家出生。

证据类型、等级与局限

  • 证据类型:基于人群的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为研究结果支持降低或取消当前IOM对肥胖孕妇的体重增长下限,并提示可能需要为3级肥胖制定单独指南。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There are concerns that current gestational weight gain recommendations for women with obesity are too high and that guidelines should differ on the basis of severity of obesity. In this study we investigated the safety of gestational weight gain below current recommendations or weight loss in pregnancies with obesity, and evaluated whether separate guidelines are needed for different obesity classes.

METHODS: In this population-based cohort study, we used electronic medical records from the Stockholm-Gotland Perinatal Cohort study to identify pregnancies with obesity (early pregnancy BMI before 14 weeks' gestation ≥30 kg/m2) among singleton pregnancies that delivered between Jan 1, 2008, and Dec 31, 2015. The pregnancy records were linked with Swedish national health-care register data up to Dec 31, 2019. Gestational weight gain was calculated as the last measured weight before or at delivery minus early pregnancy weight (at <14 weeks' gestation), and standardised for gestational age into z-scores. We used Poisson regression to assess the association of gestational weight gain z-score with a composite outcome of: stillbirth, infant death, large for gestational age and small for gestational age at birth, preterm birth, unplanned caesarean delivery, gestational diabetes, pre-eclampsia, excess postpartum weight retention, and new-onset longer-term maternal cardiometabolic disease after pregnancy, weighted to account for event severity. We calculated rate ratios (RRs) for our composite adverse outcome along the weight gain z-score continuum, compared with a reference of the current lower limit for gestational weight gain recommended by the US Institute of Medicine (IOM; 5 kg at term). RRs were adjusted for confounding factors (maternal age, height, parity, early pregnancy BMI, early pregnancy smoking status, prepregnancy cardiovascular disease or diabetes, education, cohabitation status, and Nordic country of birth).

FINDINGS: Our cohort comprised 15 760 pregnancies with obesity, followed up for a median of 7·9 years (IQR 5·8-9·4). 11 667 (74·0%) pregnancies had class 1 obesity, 3160 (20·1%) had class 2 obesity, and 933 (5·9%) had class 3 obesity. Among these pregnancies, 1623 (13·9%), 786 (24·9%), and 310 (33·2%), respectively, had weight gain during pregnancy below the lower limit of the IOM recommendation (5 kg). In pregnancies with class 1 or 2 obesity, gestational weight gain values below the lower limit of the IOM recommendation or weight loss did not increase risk of the adverse composite outcome (eg, at weight gain z-score -2·4, corresponding to 0 kg at 40 weeks: adjusted RR 0·97 [95% CI 0·89-1·06] in obesity class 1 and 0·96 [0·86-1·08] in obesity class 2). In pregnancies with class 3 obesity, weight gain values below the IOM limit or weight loss were associated with reduced risk of the adverse composite outcome (eg, adjusted RR 0·81 [0·71-0·89] at weight gain z-score -2·4, or 0 kg).

INTERPRETATION: Our findings support calls to lower or remove the lower limit of current IOM recommendations for pregnant women with obesity, and suggest that separate guidelines for class 3 obesity might be warranted.

FUNDING: Karolinska Institutet and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Johansson K, Bodnar LM, Stephansson O, et al. Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study. Lancet. 2024. PMID: 38555927. doi:10.1016/S0140-6736(24)00255-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。